From the Wires
68% of Pharmaceutical Companies Rely on Online Databases for Trade Secrets
68% of Pharmaceutical Companies Rely on Online Databases for Trade Secrets
Apr. 26, 2005 11:30 AM
RESEARCH TRIANGLE PARK, N.C., April 26 /PRNewswire/ -- A new study finds that 68% of pharmaceutical companies rely on online databases to learn trade secrets and target competitor activities. Online databases are one of the most popular tools for collecting competitive intelligence (CI) data, according to pharmaceutical business intelligence leader Cutting Edge Information ( http://www.pharmacompetitiveintelligence.com/ ).
In addition to providing competitive intelligence professionals with critical information, online databases help senior leaders execute functions from R&D and clinical development to licensing sales and marketing.
"Competitive intelligence work is crucial to a pharmaceutical company's individual brands, therapeutic areas and overall corporate strategies. Tactical competitive intelligence collection, which includes scouring internal and external databases for competitive information, assists the company in retrieving critical information, which may reveal trade secrets and competitor activities," said Elio Evangelista, senior analyst at Cutting Edge Information. "Competitive intelligence teams gain a more comprehensive understanding of a company's technical infrastructure by analyzing online databases."
Cutting Edge Information's latest report, "Pharmaceutical Competitive Intelligence: Building Strategic Advantage," available at http://www.pharmacompetitiveintelligence.com/ , is a comprehensive study featuring metrics and case studies from 18 top pharmaceutical and biotechnology companies. The report profiles competitive intelligence teams from Novartis, Wyeth, AstraZeneca, Sanofi-Aventis, Pfizer and Eli Lilly.
The study shows that competitive intelligence teams benefit from having senior leadership in place. Senior leaders have a stronger voice to communicate CI successes. Regardless of title, though, strong competitive intelligence leaders are able to communicate their successes and win greater resources for their teams.
In the study, Cutting Edge Information focuses its research on the following core areas:
* Detailed, phase-by-phase competitive intelligence team budget and
staffing levels
* Key CI activities and timelines
* The impact of centralized and decentralized organizational structures
* Competitive intelligence's role across the commercialization
organization
* Creating a competitive intelligence culture within the company
To download a free summary of this 129-page report, please visit http://www.pharmacompetitiveintelligence.com/ . For more information on "Pharmaceutical Competitive Intelligence: Building Strategic Advantage," please call Elio Evangelista at 919-433-0214 or e-mail elio_evangelista@cuttingedgeinfo.com .
Senior Analyst Elio Evangelista is a research project leader with Cutting Edge Information. Mr. Evangelista's customized research work in competitive intelligence, cardiovascular marketing, market research, and key opinion leader management practices are currently in place at several Fortune 500 companies.
Cutting Edge Information
CONTACT: Elio Evangelista of Cutting Edge Information, +1-919-433-0214,
or elio_evangelista@cuttingedgeinfo.com
Web site: http://www.cuttingedgeinfo.com/
http://www.pharmacompetitiveintelligence.com/
About PR NewswireCopyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
About Newsfeeds / Video Feeds
.gif)
